Benchmarking antibody discovery fidelity and reproducibility with an assay-locked residue fidelity index.

Reproducibility in antibody discovery is undermined by dropout, paratope degeneracy, and immunogen imprinting. Although guidelines exist, the field lacks a shared, assay-locked metric to benchmark these liabilities across discovery pipelines. We prop…

Preview only. Read the full abstract at the source